A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

Gelibter, Alain J; Gamucci, Teresa; Pollera, Camillo F; Di Costanzo, Francesco; Nuzzo, Carmen; Gabriele, Angela; Signorelli, Carlo; Gasperoni, Silvia; Ferraresi, Virginia; Giannarelli, Diana; Cognetti, Francesco; Zeuli, Massimo

Gelibter, Alain J; Gamucci, Teresa; Pollera, Camillo F; Di Costanzo, Francesco; Nuzzo, Carmen; Gabriele, Angela; Signorelli, Carlo; Gasperoni, Silvia; Ferraresi, Virginia; Giannarelli, Diana; Cognetti, Francesco; Zeuli, Massimo.

Affiliation

Gelibter AJ; Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. agelibter@yahoo.it

Curr Med Res Opin ; 23(9): 2117-23, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17651538

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Capecitabine; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Female; Fluorouracil/administration & dosage; Fluorouracil/analogs & derivatives; Gefitinib; Humans; Male; Middle Aged; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Quinazolines/administration & dosage; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 2007 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links